According to the FDA, the operators were procuring lower-cost medicines from other states and allegedly filling them into new vials before relabelling them to resemble expensive multinational and imported drug brands.
Stories That Soar Beyond Headlines
According to the FDA, the operators were procuring lower-cost medicines from other states and allegedly filling them into new vials before relabelling them to resemble expensive multinational and imported drug brands.